Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters
Tarih
2009Yazar
Yildiz, Mustafa
Seymen, Pınar
Turkmen, M. F.
Titiz, M. I.
Seymen, Hakkı Oktay
Üst veri
Tüm öğe kaydını gösterÖzet
Objective. In renal transplant recipients, cyclosporine treatment appears to cause more frequent hyperlipidemia than tacrolimus usage. In this study, hyperlipidemic renal transplant recipients who use cyclosporine were investigated for changes in high-density lipoprotein (HDL)-2/3, apolipoprotein (Apo) A1/B, other lipid and biochemical parameters, and body mass index after prospective cyclosporine to tacrolimus switching.
Bağlantı
http://hdl.handle.net/20.500.12627/13938https://doi.org/10.1016/j.transproceed.2009.09.069
Koleksiyonlar
- Makale [92796]